ホーム › 急性骨髄性白血病 › コロラド州 › Aurora
Aurora、COにおける急性骨髄性白血病の臨床試験
Auroraとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
被験者募集中観察研究
- Children's Hospital Colorado, Aurora
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Rocky Mountain Cancer Centers, Aurora
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
被験者募集中第1相
- Children's Hospital Colorado, Aurora
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- Children's Hospital Colorado, Aurora
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
被験者募集中第1/2相
- University of Colorado, Aurora
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
被験者募集中第1相
- University of Colorado Hospital, Aurora
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
被験者募集中第1相
- Anshutz Cancer Pavilion, Aurora
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Children's Hospital Colorado, Aurora
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Children's Hospital Colorado, Aurora
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
被験者募集中第3相
- University of Colorado, Aurora
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
被験者募集中第1相
- Children's Hospital Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
被験者募集中第2相
- University of Colorado, Aurora
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
被験者募集中第1相
- University of Colorado, Aurora
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- Rocky Mountain Cancer Centers, Aurora
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Baldwin Park, CA40件の研究
- Seattle, WA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA30件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Auroraにおける他の研究
- がん（全種類）35件の研究
- 大腸癌32件の研究
- 非小細胞肺癌30件の研究
- 乳がん27件の研究
- 転移性癌25件の研究
- 卵巣がん25件の研究
- 1型糖尿病23件の研究
- 肥満症21件の研究
- 肺がん19件の研究
- 前立腺がん19件の研究
- 心不全18件の研究
- 悪性黒色腫18件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。